Other OTC Pharmaceuticals (Pharmacies) - Laos

  • Laos
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$3.14m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.84%, resulting in a market volume of US$3.44m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.41 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Laos has been steadily developing in recent years, driven by changing customer preferences, emerging trends, and local special circumstances.

Customer preferences:
Laotian consumers are increasingly seeking convenience and accessibility when it comes to purchasing over-the-counter (OTC) pharmaceutical products. With the rise of e-commerce and online shopping platforms, more and more customers are opting to purchase OTC medications from online pharmacies. This shift in customer preferences is mainly driven by the convenience of doorstep delivery, wider product selection, and competitive pricing offered by online platforms. Additionally, the younger generation is more inclined towards using digital platforms for their healthcare needs, further fueling the growth of online pharmacies in Laos.

Trends in the market:
One of the key trends in the Other OTC Pharmaceuticals (Pharmacies) market in Laos is the growing demand for natural and herbal remedies. Laotian consumers are increasingly turning towards traditional medicine and natural remedies for their healthcare needs. This trend is driven by the perception that natural products are safer and have fewer side effects compared to conventional pharmaceuticals. As a result, there has been a surge in the availability and sales of herbal and natural OTC products in pharmacies across the country. Another significant trend in the market is the increasing focus on preventive healthcare. Laotian consumers are becoming more health-conscious and are taking proactive measures to maintain their well-being. This has led to a rise in the demand for OTC products such as vitamins, dietary supplements, and immune boosters. Pharmacies are capitalizing on this trend by expanding their product offerings in these categories and providing personalized recommendations to customers.

Local special circumstances:
Laos is a landlocked country with limited access to healthcare facilities, especially in rural areas. As a result, pharmacies play a crucial role in providing basic healthcare services to the population. The government of Laos has recognized the importance of pharmacies in delivering healthcare services and has implemented policies to improve the accessibility and affordability of OTC medications. This has contributed to the growth of the Other OTC Pharmaceuticals (Pharmacies) market in the country.

Underlying macroeconomic factors:
Laos has been experiencing steady economic growth in recent years, leading to an increase in disposable income and improved living standards. As a result, consumers have more purchasing power and are willing to spend on healthcare products. This has created a favorable market environment for the Other OTC Pharmaceuticals (Pharmacies) sector to thrive. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Laos is developing due to changing customer preferences, emerging trends, and local special circumstances. The shift towards online pharmacies, the growing demand for natural and herbal remedies, and the focus on preventive healthcare are driving the market growth. Additionally, the role of pharmacies in providing healthcare services and the favorable macroeconomic factors in Laos are contributing to the development of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)